Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study to Treat Bacterial Vaginosis

ClinicalTrials.gov ID: NCT01621399

Public ClinicalTrials.gov record NCT01621399. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 7:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Product 55394 in the Treatment of Bacterial Vaginosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if product 55394 is safe and efficacious for the treatment of bacterial vaginosis.

Study identification

NCT ID
NCT01621399
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
651 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2012
Primary completion
Sep 30, 2012
Completion
Nov 30, 2012
Last update posted
Aug 20, 2013

2012

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
37
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Phoenix Arizona
Not listed La Mesa California
Not listed Los Angeles California
Not listed San Diego California
Not listed Torrance California
Not listed Denver Colorado
Not listed Groton Connecticut
Not listed Boyton Beach Florida
Not listed Clearwater Florida
Not listed Miami Florida
Not listed North Miami Florida
Not listed Sunrise Florida
Not listed Atlanta Georgia
Not listed Augusta Georgia
Not listed Roswell Georgia
Not listed Chicago Illinois
Not listed Marrero Louisiana
Not listed Falls River Massachusetts
Not listed Detroit Michigan
Not listed Saginaw Michigan
Not listed Lincoln Nebraska
Not listed Lawrenceville New Jersey
Not listed Neptune City New Jersey
Not listed Plainsboro New Jersey
Not listed Columbus Ohio
Not listed Jenkintown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Columbia South Carolina
Not listed Jackson Tennessee
Not listed Corpus Christi Texas
Not listed Houston Texas
Not listed Schertz Texas
Not listed Williston Vermont
Not listed Virginia Beach Virginia
Not listed Seattle Washington
Not listed Tacoma Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01621399, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2013 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01621399 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →